We can do it together: PAR1/PAR2 heterodimer signaling in VSMCs.
作者信息
Pawlinski Rafal, Holinstat Michael
出版信息
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2775-6. doi: 10.1161/ATVBAHA.111.238865.
Abstract
摘要
相似文献
1
We can do it together: PAR1/PAR2 heterodimer signaling in VSMCs.我们可以共同完成：血管平滑肌细胞中的PAR1/PAR2异二聚体信号传导
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2775-6. doi: 10.1161/ATVBAHA.111.238865.
2
Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.蛋白酶激活受体 2 调节蛋白酶激活受体 1 驱动的新生内膜增生。
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e100-6. doi: 10.1161/ATVBAHA.111.238261. Epub 2011 Sep 22.
3
Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model.蛋白酶激活受体 (PAR)2 而非 PAR1 参与了小鼠后肢缺血模型中的侧支形成和抗炎性单核细胞极化。
PLoS One. 2013 Apr 18;8(4):e61923. doi: 10.1371/journal.pone.0061923. Print 2013.
4
Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.激肽释放酶 6 通过蛋白酶激活受体 1 和蛋白酶激活受体 2 发出信号，促进神经元损伤，并加剧谷氨酸神经毒性。
J Neurochem. 2013 Oct;127(2):283-98. doi: 10.1111/jnc.12293. Epub 2013 May 27.
5
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.蛋白酶激活受体-2对于因子VIIa和Xa诱导的乳腺癌细胞信号传导、迁移及侵袭至关重要。
Cancer Res. 2006 Jan 1;66(1):307-14. doi: 10.1158/0008-5472.CAN-05-1735.
6
Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.蛋白酶激活受体-1（PAR1）和PAR2而非PAR4介导食管下括约肌的舒张。
Regul Pept. 2007 Jul 5;142(1-2):37-43. doi: 10.1016/j.regpep.2007.01.004. Epub 2007 Jan 31.
7
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.脓毒症诱导的血管损伤中受体PAR1的“角色反转”
Nat Immunol. 2007 Dec;8(12):1303-12. doi: 10.1038/ni1525. Epub 2007 Oct 28.
8
Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.蛋白酶激活受体-1和-2可介导内皮屏障保护：在凝血因子Xa信号传导中的作用。
J Thromb Haemost. 2005 Dec;3(12):2798-805. doi: 10.1111/j.1538-7836.2005.01610.x.
9
Constitutive expression of functionally active protease-activated receptors 1 and 2 in human conjunctival epithelial cells.功能性活性蛋白酶激活受体1和2在人结膜上皮细胞中的组成性表达。
Mediators Inflamm. 2006;2006(3):61359. doi: 10.1155/MI/2006/61359.
10
Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons.大鼠嗅觉系统中的蛋白酶激活受体1和2：主嗅球中多种信号通路的层特异性调节以及嗅觉感觉神经元中神经突回缩的诱导。
Neuroscience. 2007 May 25;146(3):1289-301. doi: 10.1016/j.neuroscience.2007.02.059. Epub 2007 Apr 16.
引用本文的文献
1
Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.蛋白酶激活受体1和2与乳腺癌侵袭性的相关性因肿瘤雌激素受体状态而异。
PLoS One. 2015 Aug 5;10(8):e0134932. doi: 10.1371/journal.pone.0134932. eCollection 2015.
2
Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.蛋白酶激活受体-2 影响蛋白酶激活受体-1 驱动的乳腺癌。
Cell Mol Life Sci. 2014 Jul;71(13):2517-33. doi: 10.1007/s00018-013-1498-7. Epub 2013 Nov 1.
本文引用的文献
1
Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.蛋白酶激活受体 2 调节蛋白酶激活受体 1 驱动的新生内膜增生。
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e100-6. doi: 10.1161/ATVBAHA.111.238261. Epub 2011 Sep 22.
2
Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.蛋白酶激活受体介导凝血和纤溶之间的串扰。
Blood. 2010 Dec 2;116(23):5037-44. doi: 10.1182/blood-2010-06-293126. Epub 2010 Aug 24.
3
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.脓毒症诱导的血管损伤中受体PAR1的“角色反转”
Nat Immunol. 2007 Dec;8(12):1303-12. doi: 10.1038/ni1525. Epub 2007 Oct 28.
4
Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.蛋白酶激活受体-3（PAR3）通过受体二聚化调节PAR1信号传导。
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5662-7. doi: 10.1073/pnas.0700763104. Epub 2007 Mar 21.
5
Protease-activated receptors in cardiovascular diseases.心血管疾病中的蛋白酶激活受体
Circulation. 2006 Sep 5;114(10):1070-7. doi: 10.1161/CIRCULATIONAHA.105.574830.
6
Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.阻断血小板介导的血栓形成中的蛋白酶激活受体1-4异二聚体
Circulation. 2006 Mar 7;113(9):1244-54. doi: 10.1161/CIRCULATIONAHA.105.587758. Epub 2006 Feb 27.
7
Protease-activated receptors: contribution to physiology and disease.蛋白酶激活受体：对生理和疾病的作用
Physiol Rev. 2004 Apr;84(2):579-621. doi: 10.1152/physrev.00028.2003.
8
Thrombin and platelet activation.凝血酶与血小板激活。
Chest. 2003 Sep;124(3 Suppl):18S-25S. doi: 10.1378/chest.124.3_suppl.18s.
9
International Union of Pharmacology. XXVIII. Proteinase-activated receptors.国际药理学联合会。二十八。蛋白酶激活受体。
Pharmacol Rev. 2002 Jun;54(2):203-17. doi: 10.1124/pr.54.2.203.
10
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.老狗学新招：凝血酶在血管壁生物学中的非血栓形成作用
Circ Res. 2001 May 25;88(10):987-97. doi: 10.1161/hh1001.091447.
Zotero 插件